Tripterygium hypoglaucum

DOI:

10.1186/s13002-024-00656-1

PubMed:

38395900

Comparative analyses of complete chloroplast genomes reveal interspecific difference and intraspecific variation of Tripterygium genus.

Xu KL et al (2024).

Front Plant Sci.

DOI:

10.3389/fpls.2023.1288943

PubMed:

38264022

Tripterygium hypoglaucum extract ameliorates adjuvant-induced arthritis in mice through the gut microbiota.

Hu J et al (2023).

Chin J Nat Med.

DOI:

10.1016/S1875-5364(23)60466-2

PubMed:

37879792

Suppressive effect of Tripterygium hypoglaucum (Levl.) Hutch extract on rheumatoid arthritis in mice by modulating inflammasome and bile acid metabolism.

Zheng J et al (2023).

Biomed Pharmacother.

DOI:

10.1016/j.biopha.2023.115494

PubMed:

37734264

Subchronic toxicity evaluation of Huobahuagen extract and plasma metabolic profiling analysis combined with conventional pathology methods.

Long C et al (2024).

J Appl Toxicol.

DOI:

10.1002/jat.4532

PubMed:

37697829

Network Pharmacology and Experimental Validation to Explore That Celastrol Targeting PTEN is the Potential Mechanism of Tripterygium wilfordii (Lév.) Hutch Against IgA Nephropathy.

Zhao J et al (2023).

Drug Des Devel Ther.

DOI:

10.2147/DDDT.S402503

PubMed:

36992900

Kunxian capsule alleviates renal damage by inhibiting the JAK1/STAT1 pathway in lupus nephritis.

Cheng C et al (2023).

J Ethnopharmacol.

DOI:

10.1016/j.jep.2023.116349

PubMed:

36924861

Euonymine inhibits in-stent restenosis through enhancing contractile phenotype of vascular smooth muscle cells via modulating the PTEN/AKT/mTOR signaling pathway.

Zhang L et al (2022).

Phytomedicine.

DOI:

10.1016/j.phymed.2022.154450

PubMed:

36174454

Identification of a cytochrome P450 from Tripterygium hypoglaucum (Levl.) Hutch that catalyzes polpunonic acid formation in celastrol biosynthesis.

Chen XC et al (2022).

Chin J Nat Med.

DOI:

10.1016/S1875-5364(22)60205-X

PubMed:

36162954

[Qualitative and quantitative analyses of Tripterygium hypoglaucum in Yinning Tablets, a compound traditional Chinese herbal preparation].

Wu J et al (2022).

Nan Fang Yi Ke Da Xue Xue Bao.

DOI:

10.12122/j.issn.1673-4254.2022.06.21

PubMed:

35790448

Inhibitory effects of traditional Chinese medicine colquhounia root tablet on the pharmacokinetics of tacrolimus in rats.

Feng X et al (2022).

J Ethnopharmacol.

DOI:

10.1016/j.jep.2022.115358

PubMed:

35551976

Cytotoxic terpenoids from Tripterygium hypoglaucum against human pancreatic cancer cells SW1990 by increasing the expression of Bax protein.

Chen XL et al (2022).

J Ethnopharmacol.

DOI:

10.1016/j.jep.2022.115010

PubMed:

35065248

Tripterygium hypoglaucum (Lévl.) Hutch and Its Main Bioactive Components: Recent Advances in Pharmacological Activity, Pharmacokinetics and Potential Toxicity.

Zhao J et al (2021).

Front Pharmacol.

DOI:

10.3389/fphar.2021.715359

PubMed:

34887747

The genus Tripterygium: A phytochemistry and pharmacological review.

Lv H et al (2019).

Fitoterapia.

DOI:

10.1016/j.fitote.2019.104190

PubMed:

31163199

Understanding dihydro-β-agarofuran sesquiterpenes from Tripterygium hypoglaucum as the modulators of multi-drug resistance in HepG2/Adr cells.

Yang T et al (2019).

Biochem Biophys Res Commun.

DOI:

10.1016/j.bbrc.2018.11.188

PubMed:

30528235

Anti-inflammatory abietanes diterpenoids isolated from Tripterygium hypoglaucum.

Chen XL et al (2018).

Phytochemistry.

DOI:

10.1016/j.phytochem.2018.10.001

PubMed:

30312932

Terpenoids from Tripterygium hypoglaucum and their inhibition of LPS-induced NO production.

Zhao P et al (2014).

Biosci Biotechnol Biochem.

DOI:

10.1080/09168451.2014.890035

PubMed:

25036821

Chemical comparison of Tripterygium wilfordii and Tripterygium hypoglaucum based on quantitative analysis and chemometrics methods.

Guo L et al (2014).

J Pharm Biomed Anal.

DOI:

10.1016/j.jpba.2014.03.009

PubMed:

24694566